Advanced cognitive treatment services (ACTS) associated with significant reduction in substance abuse in ex-offenders

3395.0
Substance Abuse Treatment Programs New Approaches and Best Practices to Improve Outcomes

Monday, November 4, 2013: 4:30 PM - 5:30 PM

Poster

Organizer:

Linda Joy Frazier, MA, RN, MCHES

Board 1

Sociodemographic characterization of a cohort of patients attending a buprenorphine clinic at Puerto Rico from 2011 to 2012
Martin Colon-Ramirez, Ivis Figueroa-Sanchez, Dr.PH, Geronimo Maldonado-Martinez, PhD(c), Xiomara Osorio-Gonzalez, Yesmin Perez-Suarez, Maryleem Ramirez-Alvarado, Javier Rosario-Betancourt and Ricardo Ruiz de Porras

Board 2

Auditing access to office-based therapy for opioid addiction in Massachusetts
Lello Tesema, MD, Genevieve Bergeron, MD, James Yeh, MD, Michael Soliman, MD, Rachel Hathaway, MD, Christina Pham, MD, Jeffrey Marshall, MD and Danny McCormick, MD

Board 3

Board 4

Referral sources and substance abuse treatment outcomes at discharge
Young Ik Cho, PhD, Timothy Johnson, PhD, Michael Fendrich, PhD and Lillian Pickup, RN

Board 5

Board 6

Patients' experiences with group visits for buprenorphine treatment
David Roll, MD, Erin Bettendorf and Hsiang Huang, MD, MPH

Board 7

Board 8

Board 9

Advanced cognitive treatment services (ACTS) associated with significant reduction in substance abuse in ex-offenders
Josephine Wilson, DDS, PhD, Leon Hardin, MBA, Jamie Gee, Amy Piner and Michael Ward

See individual abstracts for presenting author's disclosure statement and author's information.